| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | filamin binding | 2.64e-07 | 29 | 97 | 5 | GO:0031005 | |
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 5.05e-07 | 14 | 97 | 4 | GO:0005130 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 6.07e-07 | 34 | 97 | 5 | GO:0015125 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 1.52e-06 | 18 | 97 | 4 | GO:0008569 | |
| GeneOntologyMolecularFunction | N-acylsphingosine amidohydrolase activity | 3.83e-06 | 7 | 97 | 3 | GO:0017040 | |
| GeneOntologyMolecularFunction | GPI anchor binding | 4.32e-06 | 23 | 97 | 4 | GO:0034235 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 9.80e-06 | 28 | 97 | 4 | GO:0051959 | |
| GeneOntologyMolecularFunction | Toll-like receptor binding | 1.13e-05 | 29 | 97 | 4 | GO:0035325 | |
| GeneOntologyMolecularFunction | transporter activity | CACNG1 HTR3A PSG1 PSG3 PSG9 ABCC9 APOB TTYH3 PKD1L3 KCNIP1 CERT1 STIM1 CNGB3 SLC10A6 LRP5 TRPM8 PSG8 CHRNA10 TMC5 | 1.19e-05 | 1289 | 97 | 19 | GO:0005215 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | CACNG1 HTR3A ABCC9 TTYH3 PKD1L3 KCNIP1 STIM1 CNGB3 TRPM8 CHRNA10 TMC5 | 1.41e-05 | 459 | 97 | 11 | GO:0005216 |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 2.30e-05 | 70 | 97 | 5 | GO:1901618 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 2.30e-05 | 70 | 97 | 5 | GO:0003777 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 2.82e-05 | 73 | 97 | 5 | GO:0170055 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 3.06e-05 | 37 | 97 | 4 | GO:0045505 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 4.44e-05 | 343 | 97 | 9 | GO:0005261 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 4.81e-05 | 196 | 97 | 7 | GO:0005319 | |
| GeneOntologyMolecularFunction | channel activity | CACNG1 HTR3A ABCC9 TTYH3 PKD1L3 KCNIP1 STIM1 CNGB3 TRPM8 CHRNA10 TMC5 | 4.83e-05 | 525 | 97 | 11 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | CACNG1 HTR3A ABCC9 TTYH3 PKD1L3 KCNIP1 STIM1 CNGB3 TRPM8 CHRNA10 TMC5 | 4.92e-05 | 526 | 97 | 11 | GO:0022803 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | CACNG1 HTR3A PSG1 PSG3 PSG9 ABCC9 TTYH3 PKD1L3 KCNIP1 STIM1 CNGB3 SLC10A6 LRP5 TRPM8 PSG8 CHRNA10 TMC5 | 4.92e-05 | 1180 | 97 | 17 | GO:0022857 |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 7.73e-05 | 90 | 97 | 5 | GO:0008028 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase binding | 8.82e-05 | 149 | 97 | 6 | GO:1990782 | |
| GeneOntologyMolecularFunction | glycolipid binding | 9.38e-05 | 49 | 97 | 4 | GO:0051861 | |
| GeneOntologyMolecularFunction | gated channel activity | 2.24e-04 | 334 | 97 | 8 | GO:0022836 | |
| GeneOntologyMolecularFunction | calcium ion binding | UNC13B ACER3 ASAH2 TTYH3 PKD1L3 KCNIP1 DNAH7 STIM1 DST LRP1 LRP4 ASAH2B | 2.73e-04 | 749 | 97 | 12 | GO:0005509 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 2.77e-04 | 118 | 97 | 5 | GO:0003774 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 3.60e-04 | 193 | 97 | 6 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 4.01e-04 | 197 | 97 | 6 | GO:0022834 | |
| GeneOntologyMolecularFunction | calcium channel activity | 4.17e-04 | 129 | 97 | 5 | GO:0005262 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | CACNG1 HTR3A ABCC9 TTYH3 PKD1L3 KCNIP1 STIM1 CNGB3 SLC10A6 TRPM8 CHRNA10 TMC5 | 4.56e-04 | 793 | 97 | 12 | GO:0015075 |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 6.06e-04 | 140 | 97 | 5 | GO:0099094 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides | 6.54e-04 | 81 | 97 | 4 | GO:0016811 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on glycosyl bonds | 6.89e-04 | 144 | 97 | 5 | GO:0016798 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds | 7.33e-04 | 146 | 97 | 5 | GO:0016810 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 8.53e-04 | 151 | 97 | 5 | GO:0015085 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor binding | 8.95e-04 | 39 | 97 | 3 | GO:0070325 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CACNG1 HTR3A ABCC9 PKD1L3 KCNIP1 STIM1 CNGB3 SLC10A6 TRPM8 CHRNA10 | 1.44e-03 | 664 | 97 | 10 | GO:0008324 |
| GeneOntologyMolecularFunction | growth factor receptor binding | 1.56e-03 | 173 | 97 | 5 | GO:0070851 | |
| GeneOntologyMolecularFunction | hydrolase activity, hydrolyzing O-glycosyl compounds | 1.60e-03 | 103 | 97 | 4 | GO:0004553 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 1.93e-03 | 465 | 97 | 8 | GO:0046873 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 2.68e-03 | 16 | 97 | 2 | GO:0005041 | |
| GeneOntologyMolecularFunction | Wnt receptor activity | 3.03e-03 | 17 | 97 | 2 | GO:0042813 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 3.40e-03 | 207 | 97 | 5 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 3.47e-03 | 208 | 97 | 5 | GO:0005342 | |
| GeneOntologyMolecularFunction | apolipoprotein binding | 4.19e-03 | 20 | 97 | 2 | GO:0034185 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 4.62e-03 | 21 | 97 | 2 | GO:0030228 | |
| GeneOntologyMolecularFunction | endopeptidase activity | 4.99e-03 | 430 | 97 | 7 | GO:0004175 | |
| GeneOntologyMolecularFunction | microtubule plus-end binding | 5.06e-03 | 22 | 97 | 2 | GO:0051010 | |
| GeneOntologyMolecularFunction | coreceptor activity | 5.20e-03 | 72 | 97 | 3 | GO:0015026 | |
| GeneOntologyMolecularFunction | calmodulin binding | 5.30e-03 | 230 | 97 | 5 | GO:0005516 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a glycoprotein | 5.53e-03 | 23 | 97 | 2 | GO:0140103 | |
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | 6.62e-03 | 153 | 97 | 4 | GO:0008194 | |
| GeneOntologyMolecularFunction | collagen binding | 7.21e-03 | 81 | 97 | 3 | GO:0005518 | |
| GeneOntologyMolecularFunction | ion channel regulator activity | 8.06e-03 | 162 | 97 | 4 | GO:0099106 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 8.23e-03 | 85 | 97 | 3 | GO:0038024 | |
| GeneOntologyMolecularFunction | transmembrane transporter binding | 9.90e-03 | 172 | 97 | 4 | GO:0044325 | |
| GeneOntologyMolecularFunction | channel regulator activity | 1.03e-02 | 174 | 97 | 4 | GO:0016247 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immune response to tumor cell | 6.00e-09 | 15 | 97 | 5 | GO:0002856 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 6.00e-09 | 15 | 97 | 5 | GO:0002859 | |
| GeneOntologyBiologicalProcess | negative regulation of response to tumor cell | 3.97e-08 | 21 | 97 | 5 | GO:0002835 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response to tumor cell | 3.97e-08 | 21 | 97 | 5 | GO:0002838 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 6.52e-08 | 23 | 97 | 5 | GO:0002858 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immune response to tumor cell | 8.21e-08 | 24 | 97 | 5 | GO:0002855 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity directed against tumor cell target | 8.21e-08 | 24 | 97 | 5 | GO:0002420 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immune response to tumor cell | 1.02e-07 | 25 | 97 | 5 | GO:0002423 | |
| GeneOntologyBiologicalProcess | regulation of blood vessel remodeling | 3.77e-07 | 32 | 97 | 5 | GO:0060312 | |
| GeneOntologyBiologicalProcess | negative regulation of brown fat cell proliferation | 4.44e-07 | 14 | 97 | 4 | GO:0070348 | |
| GeneOntologyBiologicalProcess | regulation of brown fat cell proliferation | 6.03e-07 | 15 | 97 | 4 | GO:0070347 | |
| GeneOntologyBiologicalProcess | positive regulation of homophilic cell adhesion | 6.03e-07 | 15 | 97 | 4 | GO:1903387 | |
| GeneOntologyBiologicalProcess | insulin receptor internalization | 8.01e-07 | 16 | 97 | 4 | GO:0038016 | |
| GeneOntologyBiologicalProcess | brown fat cell proliferation | 1.04e-06 | 17 | 97 | 4 | GO:0070342 | |
| GeneOntologyBiologicalProcess | insulin catabolic process | 1.04e-06 | 17 | 97 | 4 | GO:1901143 | |
| GeneOntologyBiologicalProcess | granulocyte colony-stimulating factor signaling pathway | 1.04e-06 | 17 | 97 | 4 | GO:0038158 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 1.20e-06 | 40 | 97 | 5 | GO:0045953 | |
| GeneOntologyBiologicalProcess | regulation of homophilic cell adhesion | 1.34e-06 | 18 | 97 | 4 | GO:1903385 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immunity | 1.36e-06 | 41 | 97 | 5 | GO:0002716 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immunity | 2.10e-06 | 80 | 97 | 6 | GO:0002715 | |
| GeneOntologyBiologicalProcess | negative regulation of hepatocyte proliferation | 2.10e-06 | 20 | 97 | 4 | GO:2000346 | |
| GeneOntologyBiologicalProcess | negative regulation of fat cell proliferation | 2.59e-06 | 21 | 97 | 4 | GO:0070345 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated cytotoxicity | 2.72e-06 | 47 | 97 | 5 | GO:0001911 | |
| GeneOntologyBiologicalProcess | bile acid and bile salt transport | 2.72e-06 | 47 | 97 | 5 | GO:0015721 | |
| GeneOntologyBiologicalProcess | negative regulation of granulocyte differentiation | 3.15e-06 | 22 | 97 | 4 | GO:0030853 | |
| GeneOntologyBiologicalProcess | regulation of immune response to tumor cell | 3.36e-06 | 49 | 97 | 5 | GO:0002837 | |
| GeneOntologyBiologicalProcess | regulation of response to tumor cell | 3.71e-06 | 50 | 97 | 5 | GO:0002834 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet aggregation | 3.80e-06 | 23 | 97 | 4 | GO:0090331 | |
| GeneOntologyBiologicalProcess | negative regulation of cell killing | 4.52e-06 | 52 | 97 | 5 | GO:0031342 | |
| GeneOntologyBiologicalProcess | positive regulation of vasculogenesis | 4.54e-06 | 24 | 97 | 4 | GO:2001214 | |
| GeneOntologyBiologicalProcess | common myeloid progenitor cell proliferation | 5.39e-06 | 25 | 97 | 4 | GO:0035726 | |
| GeneOntologyBiologicalProcess | immune response to tumor cell | 6.55e-06 | 56 | 97 | 5 | GO:0002418 | |
| GeneOntologyBiologicalProcess | regulation of fat cell proliferation | 7.42e-06 | 27 | 97 | 4 | GO:0070344 | |
| GeneOntologyBiologicalProcess | negative regulation of osteoclast differentiation | 8.49e-06 | 59 | 97 | 5 | GO:0045671 | |
| GeneOntologyBiologicalProcess | negative regulation of homotypic cell-cell adhesion | 8.63e-06 | 28 | 97 | 4 | GO:0034111 | |
| GeneOntologyBiologicalProcess | regulation of vasculogenesis | 9.97e-06 | 29 | 97 | 4 | GO:2001212 | |
| GeneOntologyBiologicalProcess | negative regulation of T cell proliferation | 1.14e-05 | 107 | 97 | 6 | GO:0042130 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immunity | 1.27e-05 | 109 | 97 | 6 | GO:0002228 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet activation | 1.31e-05 | 31 | 97 | 4 | GO:0010544 | |
| GeneOntologyBiologicalProcess | regulation of ERK1 and ERK2 cascade | 1.36e-05 | 385 | 97 | 10 | GO:0070372 | |
| GeneOntologyBiologicalProcess | regulation of platelet activation | 1.48e-05 | 66 | 97 | 5 | GO:0010543 | |
| GeneOntologyBiologicalProcess | negative regulation of bone resorption | 1.49e-05 | 32 | 97 | 4 | GO:0045779 | |
| GeneOntologyBiologicalProcess | fat cell proliferation | 1.49e-05 | 32 | 97 | 4 | GO:0070341 | |
| GeneOntologyBiologicalProcess | regulation of granulocyte differentiation | 1.69e-05 | 33 | 97 | 4 | GO:0030852 | |
| GeneOntologyBiologicalProcess | negative regulation of feeding behavior | 1.69e-05 | 33 | 97 | 4 | GO:2000252 | |
| GeneOntologyBiologicalProcess | negative regulation of vascular permeability | 1.91e-05 | 34 | 97 | 4 | GO:0043116 | |
| GeneOntologyBiologicalProcess | negative regulation of bone remodeling | 1.91e-05 | 34 | 97 | 4 | GO:0046851 | |
| GeneOntologyBiologicalProcess | response to tumor cell | 2.11e-05 | 71 | 97 | 5 | GO:0002347 | |
| GeneOntologyBiologicalProcess | insulin metabolic process | 2.15e-05 | 35 | 97 | 4 | GO:1901142 | |
| GeneOntologyBiologicalProcess | lipid transport | PSG1 PSG3 PSG9 APOB CPT1B CERT1 VPS13D SURF4 SLC10A6 LRP1 PSG8 | 2.58e-05 | 506 | 97 | 11 | GO:0006869 |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte proliferation | 2.64e-05 | 124 | 97 | 6 | GO:0050672 | |
| GeneOntologyBiologicalProcess | ERK1 and ERK2 cascade | 2.75e-05 | 418 | 97 | 10 | GO:0070371 | |
| GeneOntologyBiologicalProcess | negative regulation of mononuclear cell proliferation | 2.89e-05 | 126 | 97 | 6 | GO:0032945 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity | 2.94e-05 | 76 | 97 | 5 | GO:0042269 | |
| GeneOntologyBiologicalProcess | regulation of hepatocyte proliferation | 3.00e-05 | 38 | 97 | 4 | GO:2000345 | |
| GeneOntologyBiologicalProcess | regulation of tissue remodeling | 3.16e-05 | 128 | 97 | 6 | GO:0034103 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid biosynthetic process | 3.33e-05 | 39 | 97 | 4 | GO:0045717 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte proliferation | 4.09e-05 | 134 | 97 | 6 | GO:0070664 | |
| GeneOntologyBiologicalProcess | sphingosine biosynthetic process | 4.40e-05 | 15 | 97 | 3 | GO:0046512 | |
| GeneOntologyBiologicalProcess | sphingoid biosynthetic process | 4.40e-05 | 15 | 97 | 3 | GO:0046520 | |
| GeneOntologyBiologicalProcess | regulation of platelet aggregation | 4.49e-05 | 42 | 97 | 4 | GO:0090330 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte mediated immunity | 4.50e-05 | 83 | 97 | 5 | GO:0002707 | |
| GeneOntologyBiologicalProcess | negative regulation of myeloid leukocyte differentiation | 5.05e-05 | 85 | 97 | 5 | GO:0002762 | |
| GeneOntologyBiologicalProcess | blood vessel remodeling | 5.65e-05 | 87 | 97 | 5 | GO:0001974 | |
| GeneOntologyBiologicalProcess | negative regulation of behavior | 5.91e-05 | 45 | 97 | 4 | GO:0048521 | |
| GeneOntologyBiologicalProcess | epithelial cell proliferation involved in liver morphogenesis | 6.45e-05 | 46 | 97 | 4 | GO:0072575 | |
| GeneOntologyBiologicalProcess | hepatocyte proliferation | 6.45e-05 | 46 | 97 | 4 | GO:0072574 | |
| GeneOntologyBiologicalProcess | lipid localization | PSG1 PSG3 PSG9 APOB CPT1B CERT1 VPS13D SURF4 SLC10A6 LRP1 PSG8 | 6.99e-05 | 565 | 97 | 11 | GO:0010876 |
| GeneOntologyBiologicalProcess | negative regulation of tissue remodeling | 7.02e-05 | 47 | 97 | 4 | GO:0034104 | |
| GeneOntologyBiologicalProcess | liver morphogenesis | 8.28e-05 | 49 | 97 | 4 | GO:0072576 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated immunity | 9.04e-05 | 96 | 97 | 5 | GO:0002704 | |
| GeneOntologyBiologicalProcess | regulation of homotypic cell-cell adhesion | 1.13e-04 | 53 | 97 | 4 | GO:0034110 | |
| GeneOntologyBiologicalProcess | sphingosine metabolic process | 1.26e-04 | 21 | 97 | 3 | GO:0006670 | |
| GeneOntologyBiologicalProcess | regulation of interleukin-1 production | 1.30e-04 | 165 | 97 | 6 | GO:0032652 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity | 1.38e-04 | 105 | 97 | 5 | GO:0042267 | |
| GeneOntologyBiologicalProcess | interleukin-1 production | 1.58e-04 | 171 | 97 | 6 | GO:0032612 | |
| GeneOntologyBiologicalProcess | negative regulation of T cell activation | 1.58e-04 | 171 | 97 | 6 | GO:0050868 | |
| GeneOntologyBiologicalProcess | sphingoid metabolic process | 1.67e-04 | 23 | 97 | 3 | GO:0046519 | |
| GeneOntologyBiologicalProcess | granulocyte differentiation | 1.83e-04 | 60 | 97 | 4 | GO:0030851 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid metabolic process | 1.83e-04 | 60 | 97 | 4 | GO:0045922 | |
| GeneOntologyBiologicalProcess | regulation of feeding behavior | 1.95e-04 | 61 | 97 | 4 | GO:0060259 | |
| GeneOntologyBiologicalProcess | negative regulation of innate immune response | 2.03e-04 | 114 | 97 | 5 | GO:0045824 | |
| GeneOntologyBiologicalProcess | diol biosynthetic process | 2.15e-04 | 25 | 97 | 3 | GO:0034312 | |
| GeneOntologyBiologicalProcess | protein retention in Golgi apparatus | 2.17e-04 | 5 | 97 | 2 | GO:0045053 | |
| GeneOntologyBiologicalProcess | regulation of osteoclast differentiation | 2.20e-04 | 116 | 97 | 5 | GO:0045670 | |
| GeneOntologyBiologicalProcess | tissue remodeling | 2.39e-04 | 262 | 97 | 7 | GO:0048771 | |
| GeneOntologyBiologicalProcess | ceramide catabolic process | 2.42e-04 | 26 | 97 | 3 | GO:0046514 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell differentiation | 2.81e-04 | 67 | 97 | 4 | GO:0045601 | |
| GeneOntologyBiologicalProcess | fatty acid biosynthetic process | 2.86e-04 | 191 | 97 | 6 | GO:0006633 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte cell-cell adhesion | 2.95e-04 | 192 | 97 | 6 | GO:1903038 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte mediated cytotoxicity | 3.00e-04 | 124 | 97 | 5 | GO:0001910 | |
| GeneOntologyBiologicalProcess | lipoprotein transport | 3.03e-04 | 28 | 97 | 3 | GO:0042953 | |
| GeneOntologyBiologicalProcess | negative regulation of blood coagulation | 3.14e-04 | 69 | 97 | 4 | GO:0030195 | |
| GeneOntologyBiologicalProcess | regulation of bone resorption | 3.32e-04 | 70 | 97 | 4 | GO:0045124 | |
| GeneOntologyBiologicalProcess | negative regulation of hemostasis | 3.32e-04 | 70 | 97 | 4 | GO:1900047 | |
| GeneOntologyBiologicalProcess | bone remodeling | 3.35e-04 | 127 | 97 | 5 | GO:0046849 | |
| GeneOntologyBiologicalProcess | lipoprotein localization | 3.37e-04 | 29 | 97 | 3 | GO:0044872 | |
| GeneOntologyBiologicalProcess | regulation of behavior | 3.47e-04 | 128 | 97 | 5 | GO:0050795 | |
| GeneOntologyBiologicalProcess | regulation of vascular permeability | 3.51e-04 | 71 | 97 | 4 | GO:0043114 | |
| GeneOntologyBiologicalProcess | positive regulation of MAP kinase activity | 3.60e-04 | 129 | 97 | 5 | GO:0043406 | |
| GeneOntologyCellularComponent | cell surface | DPP4 NRDC PSG1 PSG3 FZD3 PSG7 PSG9 PKD1L3 ADGRG6 HAVCR2 NPTN MRC2 TLR4 CD48 LRP1 LRP4 TRPM8 PSG8 SORL1 IL9R | 1.04e-07 | 1111 | 95 | 20 | GO:0009986 |
| GeneOntologyCellularComponent | transforming growth factor beta ligand-receptor complex | 6.99e-07 | 16 | 95 | 4 | GO:0070021 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 4.71e-06 | 25 | 95 | 4 | GO:0005858 | |
| GeneOntologyCellularComponent | inner dynein arm | 1.07e-05 | 10 | 95 | 3 | GO:0036156 | |
| GeneOntologyCellularComponent | lateral plasma membrane | 5.65e-05 | 90 | 95 | 5 | GO:0016328 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | TMEM67 ACER3 UGT2A2 APOB CERT1 ADGRG6 STIM1 UBA1 DST REEP6 SURF4 DHCR7 TRPM8 G6PC2 UGT2B11 REEP5 SORL1 | 6.61e-05 | 1293 | 95 | 17 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | TMEM67 ACER3 UGT2A2 APOB CERT1 ADGRG6 STIM1 UBA1 DST REEP6 SURF4 DHCR7 TRPM8 G6PC2 UGT2B11 REEP5 SORL1 | 7.00e-05 | 1299 | 95 | 17 | GO:0098827 |
| GeneOntologyCellularComponent | ciliary membrane | 8.48e-05 | 98 | 95 | 5 | GO:0060170 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | TMEM67 ACER3 UGT2A2 APOB CERT1 ADGRG6 STIM1 UBA1 DST REEP6 SURF4 DHCR7 TRPM8 G6PC2 UGT2B11 REEP5 SORL1 | 9.10e-05 | 1327 | 95 | 17 | GO:0042175 |
| GeneOntologyCellularComponent | dynein complex | 1.06e-04 | 54 | 95 | 4 | GO:0030286 | |
| GeneOntologyCellularComponent | receptor complex | 3.09e-04 | 581 | 95 | 10 | GO:0043235 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 3.28e-04 | 378 | 95 | 8 | GO:0034702 | |
| GeneOntologyCellularComponent | external side of plasma membrane | 5.93e-04 | 519 | 95 | 9 | GO:0009897 | |
| GeneOntologyCellularComponent | cation channel complex | 7.15e-04 | 235 | 95 | 6 | GO:0034703 | |
| GeneOntologyCellularComponent | cilium | ADCY10 TMEM67 DNAH3 PSG1 PSG3 PSG9 DNAH7 TBC1D32 DNAH12 CNGB3 PSG8 DNAH5 | 7.56e-04 | 898 | 95 | 12 | GO:0005929 |
| GeneOntologyCellularComponent | external encapsulating structure | CRISPLD2 RELN COL22A1 FREM3 PKHD1L1 FREM2 DST ANGPTL2 NGLY1 HCFC1 | 8.13e-04 | 658 | 95 | 10 | GO:0030312 |
| GeneOntologyCellularComponent | microtubule associated complex | 8.45e-04 | 161 | 95 | 5 | GO:0005875 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | CACNG1 HTR3A PSG1 PSG3 PSG9 ABCC9 KCNIP1 LRP1 LRP5 PSG8 CHRNA10 | 8.64e-04 | 785 | 95 | 11 | GO:0098797 |
| GeneOntologyCellularComponent | cytoplasmic region | 1.28e-03 | 360 | 95 | 7 | GO:0099568 | |
| GeneOntologyCellularComponent | membrane raft | 1.32e-03 | 362 | 95 | 7 | GO:0045121 | |
| GeneOntologyCellularComponent | membrane microdomain | 1.36e-03 | 364 | 95 | 7 | GO:0098857 | |
| GeneOntologyCellularComponent | neuronal cell body | ADCY10 RELN HTR3A FZD3 APOB KCNIP1 LRP1 LRP4 CHRNA10 HCFC1 SORL1 | 1.42e-03 | 835 | 95 | 11 | GO:0043025 |
| GeneOntologyCellularComponent | apical part of cell | 1.49e-03 | 592 | 95 | 9 | GO:0045177 | |
| GeneOntologyCellularComponent | basal part of cell | 1.69e-03 | 378 | 95 | 7 | GO:0045178 | |
| GeneOntologyCellularComponent | side of membrane | 2.05e-03 | 875 | 95 | 11 | GO:0098552 | |
| GeneOntologyCellularComponent | Set1C/COMPASS complex | 2.35e-03 | 16 | 95 | 2 | GO:0048188 | |
| GeneOntologyCellularComponent | axon | UNC13B ADCY10 RELN HTR3A FZD3 TBC1D24 STIM1 DST LRP1 CHRNA10 HCFC1 | 2.36e-03 | 891 | 95 | 11 | GO:0030424 |
| GeneOntologyCellularComponent | axoneme | 2.56e-03 | 207 | 95 | 5 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 2.61e-03 | 208 | 95 | 5 | GO:0097014 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | 2.64e-03 | 523 | 95 | 8 | GO:1902495 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 2.86e-03 | 530 | 95 | 8 | GO:0062023 | |
| GeneOntologyCellularComponent | microtubule | 2.96e-03 | 533 | 95 | 8 | GO:0005874 | |
| GeneOntologyCellularComponent | extracellular matrix | 2.98e-03 | 656 | 95 | 9 | GO:0031012 | |
| GeneOntologyCellularComponent | membrane protein complex | CACNG1 HTR3A PSG1 PSG3 PSG9 ABCC9 TTYH3 PKD1L3 KCNIP1 CNGB3 TLR4 LRP1 LRP5 PSG8 CHRNA10 | 3.02e-03 | 1498 | 95 | 15 | GO:0098796 |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | 3.26e-03 | 317 | 95 | 6 | GO:0032838 | |
| GeneOntologyCellularComponent | cell body | ADCY10 RELN HTR3A FZD3 APOB KCNIP1 LRP1 LRP4 CHRNA10 HCFC1 SORL1 | 3.26e-03 | 929 | 95 | 11 | GO:0044297 |
| GeneOntologyCellularComponent | transporter complex | 3.58e-03 | 550 | 95 | 8 | GO:1990351 | |
| GeneOntologyCellularComponent | somatodendritic compartment | ADCY10 RELN HTR3A NRDC FZD3 APOB KCNIP1 NPTN LRP1 LRP4 CHRNA10 HCFC1 SORL1 | 3.65e-03 | 1228 | 95 | 13 | GO:0036477 |
| GeneOntologyCellularComponent | plasma membrane raft | 4.56e-03 | 147 | 95 | 4 | GO:0044853 | |
| GeneOntologyCellularComponent | plasma membrane signaling receptor complex | 5.26e-03 | 350 | 95 | 6 | GO:0098802 | |
| GeneOntologyCellularComponent | basal plasma membrane | 5.56e-03 | 354 | 95 | 6 | GO:0009925 | |
| GeneOntologyCellularComponent | serine/threonine protein kinase complex | 5.74e-03 | 157 | 95 | 4 | GO:1902554 | |
| GeneOntologyCellularComponent | T cell receptor complex | 6.55e-03 | 163 | 95 | 4 | GO:0042101 | |
| GeneOntologyCellularComponent | apical plasma membrane | 6.78e-03 | 487 | 95 | 7 | GO:0016324 | |
| MousePheno | decreased susceptibility to Coronaviridae infection induced morbidity/mortality | 2.61e-08 | 17 | 77 | 5 | MP:0031047 | |
| MousePheno | decreased susceptibility to Riboviria infection induced morbidity/mortality | 1.37e-07 | 44 | 77 | 6 | MP:0031023 | |
| MousePheno | abnormal skeletal muscle cell glucose uptake | 2.06e-07 | 47 | 77 | 6 | MP:0031617 | |
| MousePheno | decreased susceptibility to Riboviria infection | 3.18e-07 | 82 | 77 | 7 | MP:0020914 | |
| MousePheno | decreased susceptibility to Coronaviridae infection | 3.96e-07 | 28 | 77 | 5 | MP:0020950 | |
| MousePheno | decreased susceptibility to viral infection induced morbidity/mortality | 9.06e-07 | 60 | 77 | 6 | MP:0009790 | |
| MousePheno | abnormal muscle triglyceride level | 1.47e-06 | 36 | 77 | 5 | MP:0031412 | |
| MousePheno | abnormal muscle cell glucose uptake | 1.75e-06 | 67 | 77 | 6 | MP:0004130 | |
| MousePheno | abnormal vascular wound healing | 2.91e-06 | 73 | 77 | 6 | MP:0004883 | |
| MousePheno | increased skeletal muscle triglyceride level | 4.74e-06 | 21 | 77 | 4 | MP:0031415 | |
| MousePheno | decreased susceptibility to viral infection | 5.53e-06 | 125 | 77 | 7 | MP:0002410 | |
| MousePheno | abnormal susceptibility to Coronaviridae infection | 7.02e-06 | 49 | 77 | 5 | MP:0020948 | |
| MousePheno | abnormal susceptibility to Riboviria infection | 8.12e-06 | 186 | 77 | 8 | MP:0020912 | |
| MousePheno | decreased fatty acid oxidation | 8.32e-06 | 24 | 77 | 4 | MP:0014172 | |
| MousePheno | abnormal blood vessel physiology | 9.75e-06 | 394 | 77 | 11 | MP:0000249 | |
| MousePheno | abnormal wound healing | 1.06e-05 | 193 | 77 | 8 | MP:0005023 | |
| MousePheno | abnormal vasculature physiology | 1.23e-05 | 404 | 77 | 11 | MP:0031170 | |
| MousePheno | increased abdominal fat pad weight | 1.36e-05 | 27 | 77 | 4 | MP:0009286 | |
| MousePheno | decreased circulating triglyceride level | 1.94e-05 | 275 | 77 | 9 | MP:0002644 | |
| MousePheno | decreased triglyceride level | 2.00e-05 | 348 | 77 | 10 | MP:0005318 | |
| MousePheno | abnormal cellular glucose uptake | 2.03e-05 | 102 | 77 | 6 | MP:0003925 | |
| MousePheno | abnormal skeletal muscle triglyceride level | 2.39e-05 | 31 | 77 | 4 | MP:0031413 | |
| MousePheno | decreased carbon dioxide production | 2.39e-05 | 31 | 77 | 4 | MP:0008964 | |
| MousePheno | increased insulin secretion | 2.63e-05 | 64 | 77 | 5 | MP:0003058 | |
| MousePheno | decreased respiratory quotient | 3.12e-05 | 110 | 77 | 6 | MP:0010379 | |
| MousePheno | decreased skeletal muscle cell glucose uptake | 3.91e-05 | 35 | 77 | 4 | MP:0031618 | |
| MousePheno | decreased susceptibility to infection induced morbidity/mortality | 5.09e-05 | 120 | 77 | 6 | MP:0009786 | |
| MousePheno | decreased muscle cell glucose uptake | 6.05e-05 | 39 | 77 | 4 | MP:0030022 | |
| MousePheno | abnormal glucose tolerance | CRISPLD2 DPP4 PSG1 PSG3 FZD3 PSG9 ABCC9 STIM1 ANGPTL2 SURF4 TLR4 BUB1B LRP5 PSG8 | 8.75e-05 | 787 | 77 | 14 | MP:0005291 |
| MousePheno | increased incidence of tumors by chemical induction | 1.25e-04 | 141 | 77 | 6 | MP:0004499 | |
| MousePheno | abnormal susceptibility to infection induced morbidity/mortality | 1.46e-04 | 279 | 77 | 8 | MP:0009785 | |
| MousePheno | abnormal susceptibility to viral infection | 1.46e-04 | 279 | 77 | 8 | MP:0020185 | |
| MousePheno | abnormal triglyceride level | ADCY10 CRISPLD2 WWOX PSG1 PSG3 PSG9 APOB ADGRG6 SURF4 TLR4 PSG8 G6PC2 | 1.81e-04 | 639 | 77 | 12 | MP:0000187 |
| MousePheno | decreased cellular glucose uptake | 2.03e-04 | 53 | 77 | 4 | MP:0003926 | |
| MousePheno | abnormal fatty acid oxidation | 2.18e-04 | 54 | 77 | 4 | MP:0010953 | |
| MousePheno | hemorrhage | DPP4 CASP9 APOB CERT1 ADGRG6 STIM1 TBC1D32 FREM2 MGAT2 TLR4 LRP1 LRP5 | 2.57e-04 | 664 | 77 | 12 | MP:0001914 |
| MousePheno | abnormal muscle morphology | HTR3A PSG1 PSG3 PSG9 ABCC9 CERT1 ADGRG6 STIM1 FREM2 MGAT2 DST BUB1B LRP1 PSG8 DNAH5 HCFC1 | 2.88e-04 | 1106 | 77 | 16 | MP:0002108 |
| MousePheno | abnormal brain ventricular system morphology | 2.98e-04 | 393 | 77 | 9 | MP:0002200 | |
| MousePheno | abnormal lipid oxidation | 3.50e-04 | 61 | 77 | 4 | MP:0010951 | |
| MousePheno | abnormal insulin secretion | 3.55e-04 | 171 | 77 | 6 | MP:0003564 | |
| MousePheno | increased incidence of induced tumors | 3.78e-04 | 173 | 77 | 6 | MP:0002021 | |
| MousePheno | abnormal endocrine pancreas secretion | 4.14e-04 | 176 | 77 | 6 | MP:0014195 | |
| MousePheno | abnormal respiratory quotient | 4.40e-04 | 178 | 77 | 6 | MP:0004129 | |
| MousePheno | abnormal aortic arch morphology | 4.98e-04 | 119 | 77 | 5 | MP:0004113 | |
| MousePheno | abnormal carbon dioxide production | 5.01e-04 | 67 | 77 | 4 | MP:0008962 | |
| MousePheno | decreased susceptibility to infection | 5.02e-04 | 255 | 77 | 7 | MP:0002409 | |
| MousePheno | abnormal pancreas secretion | 5.09e-04 | 183 | 77 | 6 | MP:0002694 | |
| MousePheno | decreased lipid level | CRISPLD2 WWOX PSG1 PSG3 PSG9 APOB FAR2 SURF4 DHCR7 TLR4 PSG8 G6PC2 | 5.84e-04 | 727 | 77 | 12 | MP:0014461 |
| MousePheno | situs inversus with levocardia | 6.18e-04 | 7 | 77 | 2 | MP:0011253 | |
| MousePheno | right-sided stomach | 6.46e-04 | 31 | 77 | 3 | MP:0010808 | |
| MousePheno | abnormal blood circulation | DPP4 CASP9 ABCC9 APOB CERT1 ADGRG6 STIM1 TBC1D32 FREM2 MGAT2 TLR4 LRP1 LRP5 | 6.56e-04 | 845 | 77 | 13 | MP:0002128 |
| MousePheno | abnormal incidence of induced tumors | 6.89e-04 | 269 | 77 | 7 | MP:0013151 | |
| MousePheno | abnormal pancreatic beta cell physiology | 7.30e-04 | 196 | 77 | 6 | MP:0003562 | |
| MousePheno | abnormal bone strength | 7.31e-04 | 74 | 77 | 4 | MP:0001542 | |
| MousePheno | abnormal muscle fiber mitochondrial morphology | 7.78e-04 | 33 | 77 | 3 | MP:0014342 | |
| MousePheno | abnormal large intestine morphology | 8.02e-04 | 276 | 77 | 7 | MP:0000489 | |
| MousePheno | left atrial isomerism | 8.21e-04 | 8 | 77 | 2 | MP:0008461 | |
| MousePheno | urinary incontinence | 8.21e-04 | 8 | 77 | 2 | MP:0003280 | |
| MousePheno | abnormal endocrine gland physiology | 8.45e-04 | 363 | 77 | 8 | MP:0013561 | |
| MousePheno | abnormal thoracic aorta morphology | 8.54e-04 | 134 | 77 | 5 | MP:0010468 | |
| MousePheno | abnormal endocrine pancreas physiology | 8.55e-04 | 202 | 77 | 6 | MP:0010147 | |
| MousePheno | decreased oxygen consumption | 9.35e-04 | 79 | 77 | 4 | MP:0005290 | |
| MousePheno | polyphagia | 9.80e-04 | 80 | 77 | 4 | MP:0001433 | |
| MousePheno | abnormal brain ventricle morphology | 9.87e-04 | 286 | 77 | 7 | MP:0000822 | |
| MousePheno | abnormal stomach position or orientation | 1.01e-03 | 36 | 77 | 3 | MP:0010807 | |
| MousePheno | neurodegeneration | 1.05e-03 | 468 | 77 | 9 | MP:0002229 | |
| MousePheno | decreased bone stiffness | 1.05e-03 | 9 | 77 | 2 | MP:0013639 | |
| MousePheno | decreased susceptibility to weight loss | 1.05e-03 | 9 | 77 | 2 | MP:0010181 | |
| MousePheno | atrioventricular septal defect | 1.18e-03 | 84 | 77 | 4 | MP:0010412 | |
| MousePheno | abnormal atrioventricular septum morphology | 1.34e-03 | 87 | 77 | 4 | MP:0010592 | |
| MousePheno | neuron degeneration | 1.36e-03 | 391 | 77 | 8 | MP:0003224 | |
| MousePheno | abnormal colon morphology | 1.50e-03 | 152 | 77 | 5 | MP:0000495 | |
| MousePheno | pulmonary artery hypoplasia | 1.59e-03 | 11 | 77 | 2 | MP:0010460 | |
| MousePheno | abnormal gas homeostasis | 1.62e-03 | 600 | 77 | 10 | MP:0003948 | |
| Domain | Dynein_heavy_chain_D4_dom | 6.31e-07 | 14 | 96 | 4 | IPR024317 | |
| Domain | Dynein_heavy_dom-2 | 6.31e-07 | 14 | 96 | 4 | IPR013602 | |
| Domain | DHC_N2 | 6.31e-07 | 14 | 96 | 4 | PF08393 | |
| Domain | AAA_8 | 6.31e-07 | 14 | 96 | 4 | PF12780 | |
| Domain | Ldl_recept_b | 6.31e-07 | 14 | 96 | 4 | PF00058 | |
| Domain | LDLRB | 6.31e-07 | 14 | 96 | 4 | PS51120 | |
| Domain | DHC_fam | 8.57e-07 | 15 | 96 | 4 | IPR026983 | |
| Domain | Dynein_heavy_dom | 8.57e-07 | 15 | 96 | 4 | IPR004273 | |
| Domain | Dynein_heavy | 8.57e-07 | 15 | 96 | 4 | PF03028 | |
| Domain | LY | 8.57e-07 | 15 | 96 | 4 | SM00135 | |
| Domain | LDLR_classB_rpt | 8.57e-07 | 15 | 96 | 4 | IPR000033 | |
| Domain | Ig_2 | 2.03e-06 | 73 | 96 | 6 | PF13895 | |
| Domain | 6-blade_b-propeller_TolB-like | 3.75e-06 | 46 | 96 | 5 | IPR011042 | |
| Domain | V-set | 4.83e-06 | 184 | 96 | 8 | PF07686 | |
| Domain | - | PSG1 PSG3 PSG7 PSG9 VSTM2B PKHD1L1 HAVCR2 NPTN CD48 PSG8 HCFC2 HCFC1 SORL1 IL9R | 7.15e-06 | 663 | 96 | 14 | 2.60.40.10 |
| Domain | Ig_V-set | 8.58e-06 | 199 | 96 | 8 | IPR013106 | |
| Domain | Ig-like_fold | PSG1 PSG3 PSG7 PSG9 VSTM2B PKHD1L1 HAVCR2 NPTN CD48 PSG8 HCFC2 HCFC1 SORL1 IL9R | 1.45e-05 | 706 | 96 | 14 | IPR013783 |
| Domain | Ceramidse_alk_C | 2.61e-05 | 2 | 96 | 2 | PF17048 | |
| Domain | NEUT/ALK_ceramidase_C | 2.61e-05 | 2 | 96 | 2 | IPR031331 | |
| Domain | Ceramidase_alk | 2.61e-05 | 2 | 96 | 2 | IPR006823 | |
| Domain | Dynein_HC_stalk | 4.60e-05 | 14 | 96 | 3 | IPR024743 | |
| Domain | MT | 4.60e-05 | 14 | 96 | 3 | PF12777 | |
| Domain | ATPase_dyneun-rel_AAA | 4.60e-05 | 14 | 96 | 3 | IPR011704 | |
| Domain | AAA_5 | 4.60e-05 | 14 | 96 | 3 | PF07728 | |
| Domain | - | 4.70e-05 | 39 | 96 | 4 | 2.120.10.30 | |
| Domain | LDLR_class-A_CS | 5.20e-05 | 40 | 96 | 4 | IPR023415 | |
| Domain | Ldl_recept_a | 8.31e-05 | 45 | 96 | 4 | PF00057 | |
| Domain | - | 9.06e-05 | 46 | 96 | 4 | 4.10.400.10 | |
| Domain | LDLRA_1 | 1.07e-04 | 48 | 96 | 4 | PS01209 | |
| Domain | LDLRA_2 | 1.16e-04 | 49 | 96 | 4 | PS50068 | |
| Domain | LDrepeatLR_classA_rpt | 1.16e-04 | 49 | 96 | 4 | IPR002172 | |
| Domain | LDLa | 1.16e-04 | 49 | 96 | 4 | SM00192 | |
| Domain | IG | 3.17e-04 | 421 | 96 | 9 | SM00409 | |
| Domain | Ig_sub | 3.17e-04 | 421 | 96 | 9 | IPR003599 | |
| Domain | TB2_DP1_HVA22 | 3.87e-04 | 6 | 96 | 2 | IPR004345 | |
| Domain | TB2_DP1_HVA22 | 3.87e-04 | 6 | 96 | 2 | PF03134 | |
| Domain | ig | 4.45e-04 | 190 | 96 | 6 | PF00047 | |
| Domain | Immunoglobulin | 4.45e-04 | 190 | 96 | 6 | IPR013151 | |
| Domain | Calx_beta | 7.17e-04 | 8 | 96 | 2 | SM00237 | |
| Domain | AAA+_ATPase | 8.85e-04 | 144 | 96 | 5 | IPR003593 | |
| Domain | AAA | 8.85e-04 | 144 | 96 | 5 | SM00382 | |
| Domain | Calx_beta | 9.19e-04 | 9 | 96 | 2 | IPR003644 | |
| Domain | Calx-beta | 9.19e-04 | 9 | 96 | 2 | PF03160 | |
| Domain | Sialidases | 9.19e-04 | 9 | 96 | 2 | IPR011040 | |
| Domain | IG_LIKE | 9.54e-04 | 491 | 96 | 9 | PS50835 | |
| Domain | Ig-like_dom | 1.13e-03 | 503 | 96 | 9 | IPR007110 | |
| Domain | IGc2 | 1.34e-03 | 235 | 96 | 6 | SM00408 | |
| Domain | Ig_sub2 | 1.34e-03 | 235 | 96 | 6 | IPR003598 | |
| Domain | Kelch_2 | 1.97e-03 | 13 | 96 | 2 | IPR011498 | |
| Domain | Kelch_2 | 1.97e-03 | 13 | 96 | 2 | PF07646 | |
| Domain | Kelch-typ_b-propeller | 2.85e-03 | 55 | 96 | 3 | IPR015915 | |
| Domain | Gal_Oxase/kelch_b-propeller | 3.47e-03 | 59 | 96 | 3 | IPR011043 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 1.38e-05 | 27 | 78 | 4 | M47755 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_SOST_LRP4 | 5.68e-05 | 14 | 78 | 3 | M47834 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 9.09e-05 | 43 | 78 | 4 | M47669 | |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | 9.71e-05 | 194 | 78 | 7 | M16312 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 1.09e-04 | 45 | 78 | 4 | M47670 | |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | 2.38e-04 | 158 | 78 | 6 | MM14812 | |
| Pathway | WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES | 2.46e-04 | 381 | 78 | 9 | M48063 | |
| Pubmed | 5.17e-12 | 17 | 98 | 6 | 31676858 | ||
| Pubmed | 4.70e-10 | 15 | 98 | 5 | 25363763 | ||
| Pubmed | 1.81e-09 | 19 | 98 | 5 | 22496641 | ||
| Pubmed | In vivo validation of late-onset Alzheimer's disease genetic risk factors. | 8.14e-09 | 25 | 98 | 5 | 38687251 | |
| Pubmed | 2.17e-08 | 3 | 98 | 3 | 2341148 | ||
| Pubmed | A mouse carcinoembryonic antigen gene family member is a calcium-dependent cell adhesion molecule. | 4.16e-08 | 13 | 98 | 4 | 1985902 | |
| Pubmed | CEACAM1+ myeloid cells control angiogenesis in inflammation. | 4.16e-08 | 13 | 98 | 4 | 19273835 | |
| Pubmed | Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1. | 4.16e-08 | 13 | 98 | 4 | 16638824 | |
| Pubmed | 4.16e-08 | 13 | 98 | 4 | 20044046 | ||
| Pubmed | 4.16e-08 | 13 | 98 | 4 | 32150576 | ||
| Pubmed | 4.16e-08 | 13 | 98 | 4 | 6265583 | ||
| Pubmed | 4.16e-08 | 13 | 98 | 4 | 34440862 | ||
| Pubmed | CEACAM1 is a potent regulator of B cell receptor complex-induced activation. | 4.16e-08 | 13 | 98 | 4 | 12832451 | |
| Pubmed | 4.16e-08 | 13 | 98 | 4 | 25406283 | ||
| Pubmed | Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor. | 4.16e-08 | 13 | 98 | 4 | 21670291 | |
| Pubmed | 4.16e-08 | 13 | 98 | 4 | 22162753 | ||
| Pubmed | 4.16e-08 | 13 | 98 | 4 | 2702644 | ||
| Pubmed | 4.16e-08 | 13 | 98 | 4 | 8380065 | ||
| Pubmed | 4.16e-08 | 13 | 98 | 4 | 1279194 | ||
| Pubmed | 4.16e-08 | 13 | 98 | 4 | 25724769 | ||
| Pubmed | 4.16e-08 | 13 | 98 | 4 | 26374765 | ||
| Pubmed | CEACAM1 deficiency delays important wound healing processes. | 4.16e-08 | 13 | 98 | 4 | 22092845 | |
| Pubmed | 4.16e-08 | 13 | 98 | 4 | 11801635 | ||
| Pubmed | 4.16e-08 | 13 | 98 | 4 | 28913658 | ||
| Pubmed | Expression of the Bgp gene and characterization of mouse colon biliary glycoprotein isoforms. | 4.16e-08 | 13 | 98 | 4 | 8500759 | |
| Pubmed | Mouse susceptibility to mouse hepatitis virus infection is linked to viral receptor genotype. | 4.16e-08 | 13 | 98 | 4 | 9343248 | |
| Pubmed | Ceacam1 deletion causes vascular alterations in large vessels. | 4.16e-08 | 13 | 98 | 4 | 23800882 | |
| Pubmed | 4.16e-08 | 13 | 98 | 4 | 19285068 | ||
| Pubmed | 4.16e-08 | 13 | 98 | 4 | 21760897 | ||
| Pubmed | 4.16e-08 | 13 | 98 | 4 | 1719235 | ||
| Pubmed | Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. | 4.16e-08 | 13 | 98 | 4 | 1326665 | |
| Pubmed | Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation. | 4.16e-08 | 13 | 98 | 4 | 39168268 | |
| Pubmed | 4.16e-08 | 13 | 98 | 4 | 8402684 | ||
| Pubmed | 4.16e-08 | 13 | 98 | 4 | 16619040 | ||
| Pubmed | 4.16e-08 | 13 | 98 | 4 | 29377208 | ||
| Pubmed | Expression of MHV-A59 receptor glycoproteins in susceptible and resistant strains of mice. | 4.16e-08 | 13 | 98 | 4 | 8209741 | |
| Pubmed | 4.16e-08 | 13 | 98 | 4 | 27002145 | ||
| Pubmed | Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis. | 4.16e-08 | 13 | 98 | 4 | 21949477 | |
| Pubmed | 4.16e-08 | 13 | 98 | 4 | 26219866 | ||
| Pubmed | 4.16e-08 | 13 | 98 | 4 | 2133556 | ||
| Pubmed | 4.16e-08 | 13 | 98 | 4 | 32521208 | ||
| Pubmed | 4.16e-08 | 13 | 98 | 4 | 19406938 | ||
| Pubmed | 4.16e-08 | 13 | 98 | 4 | 19621080 | ||
| Pubmed | CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection. | 4.16e-08 | 13 | 98 | 4 | 29967450 | |
| Pubmed | Expression of newly identified secretory CEACAM1(a) isoforms in the intestinal epithelium. | 4.16e-08 | 13 | 98 | 4 | 19358828 | |
| Pubmed | 4.16e-08 | 13 | 98 | 4 | 16680193 | ||
| Pubmed | 4.16e-08 | 13 | 98 | 4 | 1653760 | ||
| Pubmed | Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1. | 4.16e-08 | 13 | 98 | 4 | 34058224 | |
| Pubmed | 4.16e-08 | 13 | 98 | 4 | 10964771 | ||
| Pubmed | 4.16e-08 | 13 | 98 | 4 | 32169849 | ||
| Pubmed | 4.16e-08 | 13 | 98 | 4 | 22469976 | ||
| Pubmed | CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation. | 4.16e-08 | 13 | 98 | 4 | 21532628 | |
| Pubmed | Structural and Molecular Evidence Suggesting Coronavirus-driven Evolution of Mouse Receptor. | 4.16e-08 | 13 | 98 | 4 | 28035001 | |
| Pubmed | Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice. | 4.16e-08 | 13 | 98 | 4 | 15316023 | |
| Pubmed | In vivo adaptation and persistence of Neisseria meningitidis within the nasopharyngeal mucosa. | 4.16e-08 | 13 | 98 | 4 | 23935487 | |
| Pubmed | 4.16e-08 | 13 | 98 | 4 | 15331748 | ||
| Pubmed | 4.16e-08 | 13 | 98 | 4 | 22673933 | ||
| Pubmed | Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1. | 4.16e-08 | 13 | 98 | 4 | 22406619 | |
| Pubmed | 4.16e-08 | 13 | 98 | 4 | 7628460 | ||
| Pubmed | Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance. | 4.16e-08 | 13 | 98 | 4 | 25972571 | |
| Pubmed | 4.16e-08 | 13 | 98 | 4 | 19008452 | ||
| Pubmed | 4.16e-08 | 13 | 98 | 4 | 18544705 | ||
| Pubmed | Expression of the mouse hepatitis virus receptor by central nervous system microglia. | 4.16e-08 | 13 | 98 | 4 | 15220458 | |
| Pubmed | 4.16e-08 | 13 | 98 | 4 | 18843289 | ||
| Pubmed | 4.16e-08 | 13 | 98 | 4 | 15207636 | ||
| Pubmed | 4.16e-08 | 13 | 98 | 4 | 21081647 | ||
| Pubmed | 4.16e-08 | 13 | 98 | 4 | 11133662 | ||
| Pubmed | 4.16e-08 | 13 | 98 | 4 | 11483763 | ||
| Pubmed | 4.16e-08 | 13 | 98 | 4 | 2164599 | ||
| Pubmed | 4.16e-08 | 13 | 98 | 4 | 29396368 | ||
| Pubmed | 4.16e-08 | 13 | 98 | 4 | 18003729 | ||
| Pubmed | 4.16e-08 | 13 | 98 | 4 | 26284027 | ||
| Pubmed | CEACAM1 specifically suppresses B cell receptor signaling-mediated activation. | 4.16e-08 | 13 | 98 | 4 | 33352461 | |
| Pubmed | 4.16e-08 | 13 | 98 | 4 | 38381498 | ||
| Pubmed | 4.16e-08 | 13 | 98 | 4 | 20739537 | ||
| Pubmed | 4.16e-08 | 13 | 98 | 4 | 1633107 | ||
| Pubmed | The role of CEA-related cell adhesion molecule-1 (CEACAM1) in vascular homeostasis. | 4.16e-08 | 13 | 98 | 4 | 27695943 | |
| Pubmed | 4.16e-08 | 13 | 98 | 4 | 20404914 | ||
| Pubmed | 4.16e-08 | 13 | 98 | 4 | 26911181 | ||
| Pubmed | Hepatic CEACAM1 expression indicates donor liver quality and prevents early transplantation injury. | 4.16e-08 | 13 | 98 | 4 | 32027621 | |
| Pubmed | 4.16e-08 | 13 | 98 | 4 | 30664851 | ||
| Pubmed | Role for hepatic CEACAM1 in regulating fatty acid metabolism along the adipocyte-hepatocyte axis. | 4.16e-08 | 13 | 98 | 4 | 27777319 | |
| Pubmed | 4.16e-08 | 13 | 98 | 4 | 18848945 | ||
| Pubmed | 5.81e-08 | 14 | 98 | 4 | 37531413 | ||
| Pubmed | Human CEACAM1-LF regulates lipid storage in HepG2 cells via fatty acid transporter CD36. | 5.81e-08 | 14 | 98 | 4 | 34666041 | |
| Pubmed | 5.81e-08 | 14 | 98 | 4 | 34619794 | ||
| Pubmed | SHP1 phosphatase-dependent T cell inhibition by CEACAM1 adhesion molecule isoforms. | 5.81e-08 | 14 | 98 | 4 | 17081782 | |
| Pubmed | Loss of Ceacam1 promotes prostate cancer progression in Pten haploinsufficient male mice. | 5.81e-08 | 14 | 98 | 4 | 32209360 | |
| Pubmed | 5.81e-08 | 14 | 98 | 4 | 11994468 | ||
| Pubmed | 5.81e-08 | 14 | 98 | 4 | 11850617 | ||
| Pubmed | 5.81e-08 | 14 | 98 | 4 | 20381490 | ||
| Pubmed | CEACAM1 regulates integrin αIIbβ3-mediated functions in platelets. | 5.81e-08 | 14 | 98 | 4 | 26196244 | |
| Pubmed | 5.81e-08 | 14 | 98 | 4 | 8896983 | ||
| Pubmed | 5.81e-08 | 14 | 98 | 4 | 22962327 | ||
| Pubmed | 5.81e-08 | 14 | 98 | 4 | 17623671 | ||
| Pubmed | 5.81e-08 | 14 | 98 | 4 | 26846848 | ||
| Pubmed | CEACAM1, a SOX9 direct transcriptional target identified in the colon epithelium. | 5.81e-08 | 14 | 98 | 4 | 18794798 | |
| Pubmed | 5.81e-08 | 14 | 98 | 4 | 23469261 | ||
| Pubmed | 5.81e-08 | 14 | 98 | 4 | 18454175 | ||
| Pubmed | 5.81e-08 | 14 | 98 | 4 | 22159884 | ||
| Interaction | PSG1 interactions | 1.42e-07 | 51 | 95 | 6 | int:PSG1 | |
| Interaction | PSG4 interactions | 5.59e-06 | 8 | 95 | 3 | int:PSG4 | |
| Interaction | ZBBX interactions | 1.32e-05 | 31 | 95 | 4 | int:ZBBX | |
| Interaction | NDP interactions | 2.17e-05 | 35 | 95 | 4 | int:NDP | |
| Interaction | IGFL3 interactions | 2.78e-05 | 75 | 95 | 5 | int:IGFL3 | |
| Interaction | LITAF interactions | 3.16e-05 | 77 | 95 | 5 | int:LITAF | |
| Interaction | SCGB1D1 interactions | 3.96e-05 | 133 | 95 | 6 | int:SCGB1D1 | |
| Interaction | DEFB123 interactions | 5.44e-05 | 16 | 95 | 3 | int:DEFB123 | |
| Interaction | CELSR3 interactions | 6.50e-05 | 46 | 95 | 4 | int:CELSR3 | |
| Interaction | TAFA2 interactions | 7.08e-05 | 47 | 95 | 4 | int:TAFA2 | |
| Interaction | PATE1 interactions | 8.34e-05 | 49 | 95 | 4 | int:PATE1 | |
| Interaction | CTSG interactions | 8.68e-05 | 95 | 95 | 5 | int:CTSG | |
| Interaction | TYW3 interactions | 1.14e-04 | 53 | 95 | 4 | int:TYW3 | |
| Interaction | TMEM208 interactions | 1.22e-04 | 54 | 95 | 4 | int:TMEM208 | |
| Interaction | TAFA4 interactions | 1.31e-04 | 55 | 95 | 4 | int:TAFA4 | |
| Interaction | MEGF8 interactions | 1.41e-04 | 56 | 95 | 4 | int:MEGF8 | |
| Interaction | SDF2L1 interactions | 1.42e-04 | 322 | 95 | 8 | int:SDF2L1 | |
| Interaction | PSG3 interactions | 1.46e-04 | 22 | 95 | 3 | int:PSG3 | |
| Interaction | PSG9 interactions | 1.46e-04 | 22 | 95 | 3 | int:PSG9 | |
| Cytoband | 19q13.2 | 2.84e-05 | 164 | 98 | 5 | 19q13.2 | |
| Cytoband | 2q24.3 | 5.31e-04 | 16 | 98 | 2 | 2q24.3 | |
| Cytoband | 16p12.3 | 2.42e-03 | 34 | 98 | 2 | 16p12.3 | |
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 3.94e-10 | 11 | 72 | 5 | 1315 | |
| GeneFamily | Dyneins, axonemal | 5.29e-07 | 17 | 72 | 4 | 536 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 3.83e-06 | 163 | 72 | 7 | 590 | |
| GeneFamily | Low density lipoprotein receptors | 1.68e-05 | 13 | 72 | 3 | 634 | |
| GeneFamily | Receptor accessory proteins | 2.32e-04 | 6 | 72 | 2 | 717 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 9.65e-04 | 394 | 72 | 7 | 471 | |
| Coexpression | BYSTROEM_CORRELATED_WITH_IL5_DN | 3.83e-07 | 75 | 98 | 6 | MM605 | |
| Coexpression | GIBBONS_GENETIC_MOUSE_MODEL_LUNG_ADENOCARCINOMA_DOWN_IN_METASTASIS | 6.10e-06 | 32 | 98 | 4 | MM2 | |
| Coexpression | OUYANG_PROSTATE_CANCER_MARKERS | 8.80e-06 | 35 | 98 | 4 | MM757 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_PCA3_DN | 1.91e-05 | 87 | 98 | 5 | MM851 | |
| Coexpression | DESCARTES_FETAL_PLACENTA_TROPHOBLAST_GIANT_CELLS | 2.64e-05 | 93 | 98 | 5 | M40279 | |
| Coexpression | WANG_RESPONSE_TO_BEXAROTENE_UP | 3.15e-05 | 48 | 98 | 4 | MM531 | |
| Coexpression | KOBAYASHI_EGFR_SIGNALING_24HR_UP | 4.12e-05 | 102 | 98 | 5 | M10290 | |
| Coexpression | CUI_DEVELOPING_HEART_TRABECULAR_ATRIAL_CARDIOMYOCYTE | 5.84e-05 | 179 | 98 | 6 | M39308 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-07 | 183 | 97 | 7 | 12e876d6205af8aad74265c668b5e95b9e7487f3 | |
| ToppCell | facs-Lung-3m-Mesenchymal|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.15e-07 | 192 | 97 | 7 | 8df15085b35b86f39debd933284cb703c5dd63c2 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 2.83e-07 | 200 | 97 | 7 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Dendritic-conventional_dendritic_cell-DC_c1-CLEC9A|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.25e-06 | 157 | 97 | 6 | 19c0599a669803c4db1f174de1ce755e562a50a3 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.91e-06 | 169 | 97 | 6 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-06 | 169 | 97 | 6 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.19e-06 | 173 | 97 | 6 | c3762655caa79ac4879876f470d32578a3c93b01 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.42e-06 | 176 | 97 | 6 | 6548797336c9f4ca0f38e74a2c629e2a4defa252 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.67e-06 | 179 | 97 | 6 | 5e5f1cdf4aa66868d45b74ba91e20e848a3cbaff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.13e-06 | 184 | 97 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.13e-06 | 184 | 97 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.13e-06 | 184 | 97 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Lung-18m-Mesenchymal|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.65e-06 | 189 | 97 | 6 | bdf8db938aa0863c4fed6fa99dcffd63c8c20c31 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.65e-06 | 189 | 97 | 6 | 40cbd679dc0548bf5207e1b033c0597886ad6fe1 | |
| ToppCell | Control-Myeloid|Control / group, cell type (main and fine annotations) | 3.88e-06 | 191 | 97 | 6 | 9c4acc5f3c2f9c0c5520863bb22f391774372347 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.88e-06 | 191 | 97 | 6 | 4e4488380379ed29d7898bae4e24221e7c67eb9d | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.00e-06 | 192 | 97 | 6 | 38d7a24ae205ef91ed2e0f402d8022f2a9cdb243 | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.00e-06 | 192 | 97 | 6 | 04d155897ed075c359933080e36a4ab2150b6e9f | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.00e-06 | 192 | 97 | 6 | 84149a5c6c3b3c9b86aed77cf8e72d99ef099fab | |
| ToppCell | COPD-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 4.00e-06 | 192 | 97 | 6 | eab1105cd1a98cfcd3d74dc5c9b89e1799bba59e | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | 4.00e-06 | 192 | 97 | 6 | 354adc1354bf596fbc60dd45c0169688e6f45165 | |
| ToppCell | facs-Lung-EPCAM-18m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.00e-06 | 192 | 97 | 6 | 5876ff75e273a48e7ad8236423fb41e4ae4c0a91 | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)-D122|Adult / Lineage, Cell type, age group and donor | 4.12e-06 | 193 | 97 | 6 | cc1b6d3bf56e4a88f6fe23dd036a83cf5538c958 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.24e-06 | 194 | 97 | 6 | 3cd90d01ed5a5ce65aad8284dab2537ec16e3d7c | |
| ToppCell | facs-Kidney-nan-18m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.24e-06 | 194 | 97 | 6 | bbc625b4cc53bb7d6254fde287258e51f9171572 | |
| ToppCell | facs-Kidney-nan-18m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.24e-06 | 194 | 97 | 6 | fcd5e9238d299c41f0bf9693b56cd8c900d2112b | |
| ToppCell | Control-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 4.24e-06 | 194 | 97 | 6 | 958e648138676d46698090b4046cb484083ae449 | |
| ToppCell | facs-Kidney-nan-18m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.24e-06 | 194 | 97 | 6 | 6afc21c5fec30ab8e373e3e46ab7866204c805b6 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.24e-06 | 194 | 97 | 6 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.37e-06 | 195 | 97 | 6 | 649fd2336e963f6a150d182a53ad5dd838ca80b1 | |
| ToppCell | Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.37e-06 | 195 | 97 | 6 | 9d649ac7d2af313481069c95349efc0c68449e2b | |
| ToppCell | Immune-alveolar_macrophage_(MARCO_positive)|World / Lineage, Cell type, age group and donor | 4.37e-06 | 195 | 97 | 6 | f92114ef995e690a3bedc62c89c5fd6773d0d9f7 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.37e-06 | 195 | 97 | 6 | 79dc031258579ea328181dda33710dd897f1064a | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.37e-06 | 195 | 97 | 6 | db4270c135c392ed443670981656e3cd5b95939d | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.37e-06 | 195 | 97 | 6 | 129ad5f4253ecb1a8477cc38773e6e91ea9570b0 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.37e-06 | 195 | 97 | 6 | 3e70ee987d66d450062d5df3d7c733ccc7344470 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.37e-06 | 195 | 97 | 6 | 6365e3893e38231090ec2dbef010dec71dea3d07 | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 4.50e-06 | 196 | 97 | 6 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.91e-06 | 199 | 97 | 6 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Ciliated|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 5.05e-06 | 200 | 97 | 6 | 6a2ccc71a0cbe04a542c379b28b5006de53981c3 | |
| ToppCell | MS-IIF-Lymphocyte-T/NK-ILC|IIF / Disease, condition lineage and cell class | 5.05e-06 | 200 | 97 | 6 | edb0b252e6ff9824908d1ff7d0d42710b00949c8 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_mucous|COVID-19 / group, cell type (main and fine annotations) | 2.00e-05 | 151 | 97 | 5 | 8216462e723fec2797387929dde095370947e10a | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.64e-05 | 160 | 97 | 5 | 8bb873704895c3b35bba8af78fedbabf7df42e71 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.81e-05 | 162 | 97 | 5 | d712bc31840ad1523e3dbf884acbb428a8995001 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_11|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.15e-05 | 166 | 97 | 5 | b1bebcbe17386cb102b11d551e62d46156ce0c68 | |
| ToppCell | lung-Ciliated_Epithelia|lung / shred on tissue and cell subclass | 3.25e-05 | 167 | 97 | 5 | 26cf1cfa58ee74794449a87eb19cd896e1ec8892 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.25e-05 | 167 | 97 | 5 | 9a84f45345c75f2c8ff38a04245aadee2a26a240 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_11|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.25e-05 | 167 | 97 | 5 | e44743b20a7435c579d8e999ddc4ca119d6753f2 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.84e-05 | 173 | 97 | 5 | 279efbab7810fa60ab12ea5d09a84800df4adef0 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Mesenchymal|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.84e-05 | 173 | 97 | 5 | 66f37c1437705734b20601656fa4aa1d92ca30be | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Mesenchymal-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.84e-05 | 173 | 97 | 5 | 649b08a409095592cccf31883be69c754411280d | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_E|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.95e-05 | 174 | 97 | 5 | a1f745962a104c6f4b86b7e482da8755384c773a | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_ciliated|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.95e-05 | 174 | 97 | 5 | b8d1c556290d188f56aeefc17f03119686945fe7 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_ciliated-epi_ciliated_(14)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.95e-05 | 174 | 97 | 5 | 00cf27bc23af1472a507be31fba6245a8fdd901b | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_E|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.06e-05 | 175 | 97 | 5 | 78a86cac3e6c0d115c997d1c29ee0e24af54551f | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.17e-05 | 176 | 97 | 5 | c0a084f7a8645262d61971f094689e02bf15b113 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.17e-05 | 176 | 97 | 5 | 7b5e50eb144bf43ca0cf354a466eb58b976a79f1 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.17e-05 | 176 | 97 | 5 | cccf9201f6e2da7524b911a5961d3b227edab222 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Dendritic-conventional_dendritic_cell-DC_c1-CLEC9A|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.28e-05 | 177 | 97 | 5 | e68ad19963a3d8917dfdb81127a41c4fcbe61dd5 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.28e-05 | 177 | 97 | 5 | 1d5a071157c755f3a27a5c3143015da04ee0b0dc | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.40e-05 | 178 | 97 | 5 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.40e-05 | 178 | 97 | 5 | 3b12db04006db6e94fc45649a4b3a63b92f21a61 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.52e-05 | 179 | 97 | 5 | e880c507f11ce75d104593a4ca29f0295f8125e8 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.64e-05 | 180 | 97 | 5 | 1f1af4474f3f0ac3c0d6b1a6c875c354d36d8eec | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.89e-05 | 182 | 97 | 5 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.89e-05 | 182 | 97 | 5 | 8a8b08ac4bb3cba3541dbe234e088703842285b9 | |
| ToppCell | droplet-Heart-4Chambers-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.89e-05 | 182 | 97 | 5 | f4b74c2756989812abe4e7055ec8918f69d56025 | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.89e-05 | 182 | 97 | 5 | c84f44391932080df31c8765e363c3dff64b2bd1 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.89e-05 | 182 | 97 | 5 | e36766309c4d96a90d213ce37d3acef1029a3fdc | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.15e-05 | 184 | 97 | 5 | 689a8af81a79a4bb3123cfa01958c953eab5de98 | |
| ToppCell | facs-Heart-RV-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.15e-05 | 184 | 97 | 5 | 9c20b50f8d6ac689d41d5440c835f9db8d04758b | |
| ToppCell | P28-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.15e-05 | 184 | 97 | 5 | 924400f47e6b2cdf7b0d538df75857935cf0209b | |
| ToppCell | facs-Heart-RV-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.15e-05 | 184 | 97 | 5 | 31dbe6119a3bcd266ae5e9b340c853d9ff680dce | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.28e-05 | 185 | 97 | 5 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | 15-Airway-Epithelial-Multiciliated_cell|Airway / Age, Tissue, Lineage and Cell class | 5.28e-05 | 185 | 97 | 5 | 0998b6bf44287eebbf39249fff23fc3689e44c4e | |
| ToppCell | facs-Thymus-Epithelium-24m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.28e-05 | 185 | 97 | 5 | eaa54b76743628c89b4310be57b87fa92b75fd37 | |
| ToppCell | facs-Thymus-Epithelium-24m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.28e-05 | 185 | 97 | 5 | f7f4c921d248c637351e2e882589b99ba7f04b66 | |
| ToppCell | facs-Thymus-Epithelium-24m-Mesenchymal|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.28e-05 | 185 | 97 | 5 | ff38a15af3dec36d9993f06623591872b5d1da9a | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.42e-05 | 186 | 97 | 5 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-mature_enterocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.42e-05 | 186 | 97 | 5 | bdd9d3a432aab46e733469b362f0064d35c1ac49 | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.56e-05 | 187 | 97 | 5 | 9042bd0f57213a51503d9df2e4dce3209b7772d3 | |
| ToppCell | CV-Severe-3|Severe / Virus stimulation, Condition and Cluster | 5.56e-05 | 187 | 97 | 5 | 68cb43a73945f5e252530da25613f6b3f484b4d5 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-mo-Mac|normal_Lymph_Node / Location, Cell class and cell subclass | 5.70e-05 | 188 | 97 | 5 | e83de94a9b47a6a90e98face887eae031a322af6 | |
| ToppCell | Ciliated_cells-B-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 5.70e-05 | 188 | 97 | 5 | 606907c865bd2f11bb6474932716550f7723d858 | |
| ToppCell | COVID-19-lung-Ciliated|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.85e-05 | 189 | 97 | 5 | a2da5debd10f27b1280b40141ef0bfef007cc72c | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.85e-05 | 189 | 97 | 5 | 32e6d6285b258831b965281224ff2aaeecdcb5f5 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_3|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 5.85e-05 | 189 | 97 | 5 | 99b01893da9f9f7c9528afaffad178285211738b | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.85e-05 | 189 | 97 | 5 | cd4746ea6ae48a7dd14a2960d38d9445a738cf2c | |
| ToppCell | Control-Epithelial-Ciliated|Control / Disease state, Lineage and Cell class | 5.85e-05 | 189 | 97 | 5 | c007fccd08728db3ea99af9da91d67b9b16dabb3 | |
| ToppCell | facs-Lung-EPCAM-24m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.85e-05 | 189 | 97 | 5 | 324c81285c51f4f8bb1aef428b18fe2c549c2c11 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.85e-05 | 189 | 97 | 5 | b4b93bd10b7e3cc16e54ff73beac230f519c010a | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 5.85e-05 | 189 | 97 | 5 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.85e-05 | 189 | 97 | 5 | 385ef7bbd76c8047aeecf6542377d4213b5da5db | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.85e-05 | 189 | 97 | 5 | e76dc36a01d8ad7590b3acc4c46abfcb76857448 | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.99e-05 | 190 | 97 | 5 | 9ce7df056bfb24d70db4c3c4a2c57d89115de877 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.99e-05 | 190 | 97 | 5 | 2306aa9dbeaef3be8484a5b236605de23cd75d4c | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.99e-05 | 190 | 97 | 5 | 833481ace2800354712e2ce709d5cdfd0aed3d42 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.99e-05 | 190 | 97 | 5 | 625c08a0e5227efc46daa512fd579c3938ff76c7 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.99e-05 | 190 | 97 | 5 | 1f83f7f24288a3b9ab33c2e113e845dba96adc8a | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage_2|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.99e-05 | 190 | 97 | 5 | 6514f00d222eef08c282face7f177259bca62f0e | |
| Computational | Neighborhood of CDKN1C | 1.14e-05 | 27 | 57 | 4 | GNF2_CDKN1C | |
| Computational | Neighborhood of EGFR | 2.29e-05 | 32 | 57 | 4 | GNF2_EGFR | |
| Computational | Neighborhood of IGFBP1 | 3.29e-05 | 35 | 57 | 4 | GNF2_IGFBP1 | |
| Computational | Neighborhood of MMP11 | 6.85e-05 | 42 | 57 | 4 | GNF2_MMP11 | |
| Computational | Neighborhood of TIMP2 | 9.82e-05 | 46 | 57 | 4 | GNF2_TIMP2 | |
| Computational | Neighborhood of KISS1 | 1.26e-04 | 49 | 57 | 4 | GNF2_KISS1 | |
| Drug | AC1L1IPV | 1.07e-06 | 43 | 97 | 5 | CID000004683 | |
| Drug | Sulfamethoxypyridazine [80-35-3]; Up 200; 14.2uM; PC3; HT_HG-U133A | 2.12e-06 | 198 | 97 | 8 | 3711_UP | |
| Disease | cD177 antigen measurement | 3.24e-07 | 18 | 97 | 4 | EFO_0021866 | |
| Disease | peak expiratory flow | 3.97e-05 | 498 | 97 | 9 | EFO_0009718 | |
| Disease | hereditary spastic paraplegia 31 (implicated_via_orthology) | 1.59e-04 | 6 | 97 | 2 | DOID:0110782 (implicated_via_orthology) | |
| Disease | LDL cholesterol change measurement | 2.22e-04 | 7 | 97 | 2 | EFO_0007804 | |
| Disease | Common Migraine | 2.22e-04 | 7 | 97 | 2 | C0338480 | |
| Disease | visceral heterotaxy (implicated_via_orthology) | 2.47e-04 | 37 | 97 | 3 | DOID:0050545 (implicated_via_orthology) | |
| Disease | marginal zone B-cell lymphoma | 2.96e-04 | 8 | 97 | 2 | EFO_1000630 | |
| Disease | Meckel syndrome (implicated_via_orthology) | 2.96e-04 | 8 | 97 | 2 | DOID:0050778 (implicated_via_orthology) | |
| Disease | Acute Confusional Migraine | 3.79e-04 | 9 | 97 | 2 | C0521664 | |
| Disease | Status Migrainosus | 3.79e-04 | 9 | 97 | 2 | C0338489 | |
| Disease | Abdominal Migraine | 3.79e-04 | 9 | 97 | 2 | C0270858 | |
| Disease | Sick Headaches | 3.79e-04 | 9 | 97 | 2 | C0700438 | |
| Disease | Cervical Migraine Syndrome | 3.79e-04 | 9 | 97 | 2 | C0007852 | |
| Disease | Hemicrania migraine | 3.79e-04 | 9 | 97 | 2 | C0018984 | |
| Disease | Shortened QT interval | 5.77e-04 | 11 | 97 | 2 | C0151879 | |
| Disease | FEV/FEC ratio | KCNIP1 ADGRG6 STIM1 NPTN FREM2 DNAH12 DST MRC2 LRP1 TRPM8 DNAH5 SORL1 | 6.99e-04 | 1228 | 97 | 12 | EFO_0004713 |
| Disease | mood disorder | 8.15e-04 | 13 | 97 | 2 | EFO_0004247 | |
| Disease | Migraine Disorders | 8.15e-04 | 13 | 97 | 2 | C0149931 | |
| Disease | disease progression measurement | 1.08e-03 | 61 | 97 | 3 | EFO_0008336 | |
| Disease | Anilide use measurement | 1.09e-03 | 15 | 97 | 2 | EFO_0009938 | |
| Disease | cystic fibrosis (is_marker_for) | 1.13e-03 | 62 | 97 | 3 | DOID:1485 (is_marker_for) | |
| Disease | migraine without aura, susceptibility to, 4 | 1.25e-03 | 16 | 97 | 2 | MONDO_0011847 | |
| Disease | Major Depressive Disorder | 1.27e-03 | 243 | 97 | 5 | C1269683 | |
| Disease | theta wave measurement | 1.41e-03 | 17 | 97 | 2 | EFO_0006873 | |
| Disease | Unipolar Depression | 1.68e-03 | 259 | 97 | 5 | C0041696 | |
| Disease | Liver diseases | 1.74e-03 | 72 | 97 | 3 | C0023895 | |
| Disease | type 1 diabetes mellitus (is_marker_for) | 1.74e-03 | 72 | 97 | 3 | DOID:9744 (is_marker_for) | |
| Disease | Liver Dysfunction | 1.74e-03 | 72 | 97 | 3 | C0086565 | |
| Disease | Antimigraine preparation use measurement | 2.16e-03 | 21 | 97 | 2 | EFO_0009939 | |
| Disease | Colorectal Carcinoma | 2.22e-03 | 702 | 97 | 8 | C0009402 | |
| Disease | non-high density lipoprotein cholesterol measurement | 2.45e-03 | 713 | 97 | 8 | EFO_0005689 | |
| Disease | type 2 diabetes mellitus (is_implicated_in) | 2.48e-03 | 171 | 97 | 4 | DOID:9352 (is_implicated_in) | |
| Disease | Behcet Syndrome | 2.82e-03 | 24 | 97 | 2 | C0004943 | |
| Disease | Involutional paraphrenia | 3.05e-03 | 25 | 97 | 2 | C1571983 | |
| Disease | Psychosis, Involutional | 3.05e-03 | 25 | 97 | 2 | C1571984 | |
| Disease | Involutional Depression | 3.05e-03 | 25 | 97 | 2 | C0011574 | |
| Disease | response to interferon | 3.05e-03 | 25 | 97 | 2 | EFO_0007859 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DVWDRYISWTEQNYP | 76 | O60566 | |
| LTLYLWIRQEWTDAY | 76 | Q9GZZ6 | |
| STLDWCEENYSVTWY | 16 | Q9NUN7 | |
| CEENYSVTWYIAEFW | 21 | Q9NUN7 | |
| WNYLDWIEICHYIAT | 1166 | Q96NH3 | |
| HRDQEYEVTWYISWS | 81 | Q9HC16 | |
| WLNSTFQNWNYTVYV | 436 | Q86SQ4 | |
| WQIVCNDASWETRFY | 91 | P0C7U1 | |
| LSADPYVYNWTAWSE | 126 | Q14956 | |
| YRQYWTDEFLQWNPE | 86 | P46098 | |
| IDYWLATWTSEYSIN | 1011 | O60706 | |
| EYWLGLENIYWLTNQ | 346 | Q9UKU9 | |
| VAIWYARLQEWDNFY | 1426 | Q96PN6 | |
| LQAIYVIDFFWNETW | 276 | Q9UBM7 | |
| IDSEDTVWIEYYYSW | 166 | Q06432 | |
| TWYGEQDQAVHLWRY | 116 | O75323 | |
| YFWNVDVRNDWETTI | 461 | Q9Y5P4 | |
| YSNDLYELQASRWEW | 106 | P51610 | |
| LEYFINRSWEWSTYN | 391 | Q96K12 | |
| YSNELYELQASRWLW | 96 | Q9Y5Z7 | |
| EARYVWDYTDHVWTE | 326 | Q96IV0 | |
| YDDYNWDWTLQYLTV | 341 | Q10469 | |
| QWLWDIIDEFIYQFQ | 181 | Q9Y262 | |
| QSLVNQFWETYEELW | 5936 | Q03001 | |
| ALTLFEDYVYWTDWE | 3236 | Q07954 | |
| EDYVYWTDWETKSIN | 3241 | Q07954 | |
| WQIVCNDASWETRFY | 706 | Q9NR71 | |
| LNWAWISFEKEYYLV | 1766 | Q5SZK8 | |
| LTQYSDYIYWTDWNL | 851 | O75197 | |
| DYIYWTDWNLHSIER | 856 | O75197 | |
| WGEVWENAVYFVCNY | 186 | Q9H0B8 | |
| TYAWRFQEEEEWNDQ | 26 | Q5W188 | |
| DTDFLWLAQLRYYWE | 1186 | Q6ZR08 | |
| QDYWKAWDANYASLI | 71 | P12525 | |
| LIYNWEGEYFWTALQ | 571 | Q9UBG0 | |
| WVYEEEVFSAYSALW | 201 | P27487 | |
| DIAWWYYQYQRDKIE | 21 | Q9NZI2 | |
| WSQSYYTAQDEWALD | 1011 | P78509 | |
| DDTVWLTYWVVYALF | 81 | Q96HR9 | |
| QVYSTLVTYISDWWT | 2541 | P04114 | |
| LDTVWIYNSESDEWT | 336 | Q8NBE8 | |
| WISWDDLCQYYDVIY | 521 | Q9Y6W3 | |
| DLNDFQWISQLRYYW | 1361 | Q8TD57 | |
| EKWQTRSIYNAAVWY | 136 | Q8TF46 | |
| SWYVETLDDIFEQWA | 361 | P55211 | |
| DSDFEWLSQLRYYWQ | 1261 | Q8WXX0 | |
| WLSQLRYYWQENHLE | 1266 | Q8WXX0 | |
| RKEDWYIWQVIDQYS | 306 | Q8NFW1 | |
| YWWVQETQIYPNHSS | 81 | Q9NQR9 | |
| NDLNYRWVSLDNWTY | 66 | O00462 | |
| YEQAYRGIWETTWIQ | 441 | Q9NPG1 | |
| LSPDWQVDYESYTWR | 386 | P26641 | |
| WAQDTYSPDEYLWAT | 311 | Q02742 | |
| LTWFYTFDQKIVEWD | 56 | P09326 | |
| SNYVSDWWEEYIYLR | 231 | Q92523 | |
| WVQYLSNSTDIIESW | 1611 | Q8TE73 | |
| VTEINRENYWVTVEW | 46 | Q8N4N8 | |
| SENYTYIWWLNGQSL | 266 | P11464 | |
| SENYTYIWWLNGQSL | 266 | Q16557 | |
| EPSNDWDIYYWATEA | 111 | Q9NX18 | |
| SIWRTYFVANEWNEI | 666 | Q5HYA8 | |
| NWAWICLEKEYYIVD | 1771 | P0C091 | |
| ISVDDQWIYWTDAYL | 926 | Q92673 | |
| YYYWNTQTNEVTWEL | 231 | Q8N3X1 | |
| SENYTYIWWLNGQSL | 266 | Q9UQ74 | |
| SENYTYIWWLNGQSL | 266 | Q00887 | |
| DERDVNYWTSRYWLN | 71 | Q8TDQ0 | |
| AVTQCYYWEIHNQTW | 631 | Q7Z443 | |
| DVYTQVSAFVAWIWD | 246 | Q6UWY2 | |
| VAAWRDEDDYTWLYI | 176 | Q8ND83 | |
| YISNWFEQDDWYEGL | 6 | Q8IZU2 | |
| FQWSEQRDYIDTTWN | 46 | O15260 | |
| EDDTQWLTYWVVYGV | 81 | Q00765 | |
| VEEERYTGQWSEWSQ | 236 | Q01113 | |
| SENYTYIWWLNGQSL | 266 | Q13046 | |
| SSEVYNWTVDEVVQW | 126 | Q13586 | |
| WEEWELYQQISYAVS | 121 | Q9NY30 | |
| QKRVRTWYEYTWDSQ | 476 | Q9NQW8 | |
| VSEDVLQVYADWQRW | 201 | Q9ULP9 | |
| AYEDWVSSLDWQVYF | 516 | Q2L4Q9 | |
| KWELYNWRETDEYSA | 196 | Q9H5L6 | |
| ATSYSLEIQWWYLKE | 56 | A6NLU5 | |
| EIQWWYAEVNRAESF | 61 | Q9Y639 | |
| YSIEDIENSWAELWN | 631 | O43847 | |
| WVYYANHTEEKTQWE | 31 | Q9NZC7 | |
| YLYTWSWSLQQNLTI | 146 | Q3KNW5 | |
| WDETLYKAWSSIVYQ | 226 | Q5VZM2 | |
| EEARYWTYKWEQINA | 136 | O14795 | |
| FQEGWVLSWNEYSIY | 296 | O15040 | |
| DHWWQVSITDYVVFD | 1021 | O15040 | |
| IWTCWDYGIYFQTTE | 3481 | Q86WI1 | |
| WLYFSQEQEILWELY | 106 | O75310 | |
| QYYNQEWTLWDRFEV | 946 | P22314 | |
| IYFSEQEWQDLEAWQ | 16 | Q8N393 | |
| YYWLNTVALSGEECW | 711 | Q6UXY8 | |
| EEWEYLDSAQRNLYW | 51 | Q6P280 | |
| WYVNGVNYFTDLWNV | 786 | Q7Z2W7 | |
| YEHWQIWENYILTST | 626 | Q6P3X3 | |
| EVLAEQVDLYDWYRW | 196 | Q9C0H2 | |
| WCIFEYEIAQTWQFL | 746 | O00206 | |
| SLQDYIFQSYWGEWN | 226 | P0DTE5 | |
| REWWYFALNANLYEI | 316 | Q5THJ4 | |
| LDSYIYWTDWQTRSI | 1261 | O75096 |